Overview
HBIO market data
Price History
HBIO price chart · 1M
- O
- 8.00
- H
- 8.23
- L
- 8.00
- C
- 8.23
- Vol
- 1,527.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $8.00
- Previous Close
- $8.12
- Day High
- $8.23
- Day Low
- $8.00
- 52 Week High
- $9.31
- 52 Week Low
- $3.80
- 7 Day Return
- +0.18%
- 30 Day Return
- +2.81%
- 90 Day Return
- +36.40%
- 1 Year Return
- +90.35%
- Daily Notional Volume
- $12.6K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$12.77 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.49 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -11.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.75 – $9.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- $7.50 Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $36.4M · P/B 2.17 · P/S 0.41.
Company News
6 captured
North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion OpportunityGlobenewswire Inc ·
Harvard Bioscience Q2 Adj. EPS $(0.14) Beats $(0.21) Estimate, Sales $22.727M Beat $21.450M EstimateBenzinga ·
8-K filing — HARVARD BIOSCIENCE INC (HBIO)SEC EDGAR ·